9D20 | pdb_00009d20

Crystal structure of DLK1 in complex with ACVR2B


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.67 Å
  • R-Value Free: 
    0.242 (Depositor), 0.238 (DCC) 
  • R-Value Work: 
    0.212 (Depositor), 0.214 (DCC) 
  • R-Value Observed: 
    0.214 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9D20

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Molecular mechanism of Activin receptor inhibition by DLK1.

Antfolk, D.Ming, Q.Manturova, A.Goebel, E.J.Thompson, T.B.Luca, V.C.

(2025) Nat Commun 16: 5976-5976

  • DOI: https://doi.org/10.1038/s41467-025-60634-3
  • Primary Citation Related Structures: 
    9D20

  • PubMed Abstract: 

    Delta-like non-canonical Notch ligand 1 (DLK1) influences myogenesis, adipogenesis, and other aspects of human development through a process that is largely attributed to the downregulation of Notch signaling. Here, we show that DLK1 does not bind to Notch receptors or affect ligand-mediated Notch activation, but instead engages the TGF-β superfamily member Activin receptor type 2B (ACVR2B). The crystal structure of the DLK1-ACVR2B complex reveals that DLK1 mimics the binding mode of canonical TGF-β ligands to compete for access to ACVR2B. In functional assays, DLK1 antagonizes Myostatin-ACVR2B signaling to promote myoblast differentiation, rationalizing a mechanism for the role of DLK1 in muscle development and regeneration. Crosstalk between Notch and TGF-β is mediated by interactions between the transcriptional regulators SMAD2/3 and the Notch intracellular domain (NICD), and DLK1 inhibits SMAD2/3-NICD colocalization. These findings indicate that DLK1 acts directly on ACVR2B to inhibit signaling, whereas the observed effects on Notch may be an indirect result of DLK1 interference with NICD-SMAD complex formation.


  • Organizational Affiliation
    • Department of Immunology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

Macromolecule Content 

  • Total Structure Weight: 41.98 kDa 
  • Atom Count: 2,776 
  • Modeled Residue Count: 346 
  • Deposited Residue Count: 350 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Activin receptor type-2BA [auth E],
C [auth A]
94Homo sapiensMutation(s): 0 
Gene Names: ACVR2B
EC: 2.7.11.30
UniProt & NIH Common Fund Data Resources
Find proteins for Q13705 (Homo sapiens)
Explore Q13705 
Go to UniProtKB:  Q13705
PHAROS:  Q13705
GTEx:  ENSG00000114739 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ13705
Glycosylation
Glycosylation Sites: 2Go to GlyGen: Q13705-1
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Protein delta homolog 1B [auth D],
D [auth B]
81Homo sapiensMutation(s): 0 
Gene Names: DLK1DLK
UniProt & NIH Common Fund Data Resources
Find proteins for P80370 (Homo sapiens)
Explore P80370 
Go to UniProtKB:  P80370
PHAROS:  P80370
GTEx:  ENSG00000185559 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP80370
Glycosylation
Glycosylation Sites: 2Go to GlyGen: P80370-1
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 5 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAG

Query on NAG



Download:Ideal Coordinates CCD File
E,
F [auth E],
O [auth A],
P [auth A]
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
BGC

Query on BGC



Download:Ideal Coordinates CCD File
K [auth D],
T [auth B]
beta-D-glucopyranose
C6 H12 O6
WQZGKKKJIJFFOK-VFUOTHLCSA-N
FUC

Query on FUC



Download:Ideal Coordinates CCD File
J [auth D],
S [auth B]
alpha-L-fucopyranose
C6 H12 O5
SHZGCJCMOBCMKK-SXUWKVJYSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
H [auth E],
I [auth E],
N [auth D],
R [auth A],
U [auth B]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
EDO

Query on EDO



Download:Ideal Coordinates CCD File
G [auth E],
L [auth D],
M [auth D],
Q [auth A]
1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.67 Å
  • R-Value Free:  0.242 (Depositor), 0.238 (DCC) 
  • R-Value Work:  0.212 (Depositor), 0.214 (DCC) 
  • R-Value Observed: 0.214 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 120.98α = 90
b = 52.97β = 118.99
c = 97.99γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XSCALEdata scaling
XDSdata reduction
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR35GM133482

Revision History  (Full details and data files)

  • Version 1.0: 2025-05-07
    Type: Initial release
  • Version 1.1: 2025-07-16
    Changes: Database references